Home » Stock Quotes » STO:ACTI

Active Biotech AB STO:ACTI

Today's live share price, quote history, chart & news

2.65 SEK
-0.06 (-2.21%)
Price open 2.71
Previous close 2.71
Market cap 384.88M
Volume 176.37K
Day high 2.71
Day low 2.62
Year high 4.20
Year low 2.00

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, together with its subsidiaries, develops drugs for the treatment of neurodegenerative, inflammatory, and cancer diseases in Sweden. The company is involved in developing ANYARA, a tumor targeting superantigen to kill tumor cell; Tasquinimod, an oral immunomodulatory compound for the treatment of multiple myeloma, a form of blood cancer; and SILC, an S100A9 inhibition by low molecular weight compounds for the treatment of cancer. It is also developing Laquinimod, an oral immunomodulatory drug that has completed Phase II clinical trial for Huntington's disease; and Paquinimod, an oral immunomodulatory compound that has completed Phase I clinical trial for the treatment of systemic lupus erythematosus and systemic sclerosis. The company has a partnership agreement with NeoTX Therapeutics Ltd. for the development of naptumumab. Active Biotech AB (publ) was incorporated in 1982 and is headquartered in Lund, Sweden.

Name Active Biotech AB
Exchange Stockholm Stock Exchange
Sector Healthcare
Industry Biotechnology
Country Sweden
Full time employees 11

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.